sodium thiosulfate has been researched along with dimethyl sulfoxide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertelli, G | 1 |
| Arthaud, LE; MacDonald, JR; Marshall, RF | 1 |
| Grothe, W; Jordan, K; Schmoll, HJ | 1 |
| Almanric, K; Boulanger, J; Ducharme, A; Dufour, A; Fortier, S | 1 |
2 review(s) available for sodium thiosulfate and dimethyl sulfoxide
| Article | Year |
|---|---|
Prevention and management of extravasation of cytotoxic drugs.
Topics: Adrenal Cortex Hormones; Animals; Antidotes; Combined Modality Therapy; Dimethyl Sulfoxide; Extravasation of Diagnostic and Therapeutic Materials; Hot Temperature; Humans; Hyaluronoglucosaminidase; Infusions, Intravenous; Injections, Intravenous; Skin Diseases; Skin Transplantation; Skin Ulcer; Sodium Bicarbonate; Thiosulfates | 1995 |
Management of the extravasation of anti-neoplastic agents.
Topics: Antineoplastic Agents; Catheterization, Central Venous; Catheterization, Peripheral; Dexrazoxane; Dimethyl Sulfoxide; Extravasation of Diagnostic and Therapeutic Materials; Humans; Hyaluronoglucosaminidase; Neoplasms; Quebec; Risk Factors; Thiosulfates | 2015 |
2 other study(ies) available for sodium thiosulfate and dimethyl sulfoxide
| Article | Year |
|---|---|
Evaluation of antidotes for extravasation injury produced by 6-hydroxymethylacylfulvene (MGI 114), a novel cytotoxic antitumor agent, in an intradermal toxicity model in rats.
Topics: Administration, Cutaneous; Animals; Antidotes; Antineoplastic Agents; Cold Temperature; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Male; Rats; Rats, Inbred F344; Sesquiterpenes; Skin; Thiosulfates | 2000 |
[Extravasation of chemotherapeutic agents: prevention and therapy].
Topics: Antineoplastic Agents; Catheterization, Central Venous; Diagnosis, Differential; Dimethyl Sulfoxide; Extravasation of Diagnostic and Therapeutic Materials; Humans; Iatrogenic Disease; Peptide Hydrolases; Razoxane; Risk Factors; Thiosulfates; Time Factors | 2005 |